US2020330272A1PendingUtilityA1

Glaucoma treatment devices and methods

Assignee: MICROOPTX INCPriority: Dec 31, 2014Filed: Jun 30, 2020Published: Oct 22, 2020
Est. expiryDec 31, 2034(~8.5 yrs left)· nominal 20-yr term from priority
Inventors:J. David Brown
A61F 2220/0016A61F 9/00781A61L 27/18A61F 2250/006A61F 2220/0033A61L 27/28
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Devices can be implanted in an eye to treat glaucoma. The devices described herein include a body defining a lumen and having first and second ends and external and lumenal surfaces. The body has a length sufficient to provide fluid communication between the anterior chamber and tear film of the eye through the lumen when the device is implanted in the sclera. By the strategic selection of particular materials of construction, and/or by controlling the configuration and size of the lumen, in some embodiments, the device is a filterless construct. In some embodiments, a filter is included. The glaucoma treatment devices as provided herein are designed to prevent bacterial ingress and to provide the required level of outflow resistance to achieve a desired intraocular pressure. Methods of treating glaucoma wherein the device is implanted in the sclera of an afflicted eye are also described.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A two-piece device for treating glaucoma in an eye, the device comprising:
 a collar defining a first lumen therethrough; and   a cartridge, wherein at least a portion of the cartridge is releasably engageable within the first lumen, the cartridge defining a second lumen therethrough and having a length sufficient to provide fluid communication between an anterior chamber and a tear film of the eye through the second lumen when the device is implanted in a sclera of the eye.   
     
     
         2 . The two-piece device of  claim 1 , wherein the collar has a length sufficient to extend from an outer surface of the eye to the anterior chamber while the collar is implanted in the sclera of the eye. 
     
     
         3 . The two-piece device of  claim 1 , wherein the at least a portion of the cartridge is releasably engageable within the first lumen using a dimensional interference fit therebetween. 
     
     
         4 . The two-piece device of  claim 1 , wherein the collar includes one or more barbs configured to engage the sclera while the collar is implanted in the sclera of the eye.

Join the waitlist — get patent alerts

Track US2020330272A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.